Clinical Trial: Safety and Feasibility of NRICM301 Added to Usual Care for Adults With Acute Ischemic Stroke

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07900503) titled 'Safety and Feasibility of NRICM301 Added to Usual Care for Adults With Acute Ischemic Stroke' on Oct. 21.

Brief Summary: Acute ischemic stroke occurs when blood flow to part of the brain is blocked. This study will assess the safety and feasibility of adding NRICM301, a food-grade formula also called Taiwan Xingnao No. 1, to usual care for adults with acute ischemic stroke.

The study plans to enroll 45 participants at En Chu Kong Hospital in Taiwan. Participants will be assigned by chance in a 1:1 ratio to receive NRICM301 or a similar-looking placebo drink for 14 days, in addition to usual stroke care. Each dose is 100 mL, taken t...